T. Rowe Price Associates’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $31.8M | Buy |
|
|||||
|
2025
Q2 | $10.8M | Buy |
|
|||||
|
2025
Q1 | $7.41M | Buy |
|
|||||
|
2024
Q4 | $2.76M | Buy |
|
|||||
|
2024
Q3 | $2.45M | Buy |
|
|||||
|
2024
Q2 | $1.66M | Buy |
|
|||||
|
2024
Q1 | $1.22M | Sell |
|
|||||
|
2023
Q4 | $1.67M | Buy |
|
|||||
|
2023
Q3 | $1.33M | Buy |
|
|||||
|
2023
Q2 | $1.04M | Buy |
|
|||||
|
2023
Q1 | $993K | Buy |
|
|||||
|
2022
Q4 | $886K | Buy |
|
|||||
|
2022
Q3 | $1.06M | Buy |
|
|||||
|
2022
Q2 | $851K | Buy |
|
|||||
|
2022
Q1 | $643K | Buy |
|
|||||
|
2021
Q4 | $486K | Sell |
|
|||||
|
2021
Q3 | $842K | Buy |
|
|||||
|
2021
Q2 | $936K | Buy |
|
|||||
|
2021
Q1 | $975K | Sell |
|
|||||
|
2020
Q4 | $1.08M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $645K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $470K | Hold |
|
|||||
|
2015
Q4 | $500K | Sell |
|
|||||
|
2015
Q3 | $1.45M | Buy |
|